Skip to main content
Carasent logo

Carasent — Investor Relations & Filings

Ticker · CARA ISIN · NO0010123060 LEI · 5967007LIEEXZXI9ZS60 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2023-08-21 Director's Dealing
Country NO Norway
Listing OL CARA

About Carasent

https://carasent.com/

Carasent is a health technology group focused on enhancing efficiency and quality in the healthcare sector. The company develops and provides mission-critical, cloud-based software solutions, with a primary focus on Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems, often delivered as Software as a Service (SaaS). With over 30 years of experience, Carasent also offers a suite of integrated ecosystem services designed to automate and streamline clinical and administrative workflows. By integrating its core platforms with proprietary and third-party applications, the company creates seamless processes that reduce administrative burdens for customers in the healthcare, rehabilitation, and occupational health sectors.

Recent filings

Filing Released Lang Actions
Carasent: CEO Daniel Öhman acquires shares
Director's Dealing Classification · 99% confidence The document text explicitly states that the CEO, Daniel Öhman, has acquired shares. This action—a transaction in the company's own stock by an insider (CEO)—directly corresponds to the definition of Director's Dealing (insider trades) or Transaction in Own Shares. Since the transaction is by a director/executive, 'Director's Dealing' (DIRS) is the most precise fit, although 'Transaction in Own Shares' (POS) is also relevant. Given the context of executive trading reports, DIRS is preferred over POS which usually refers to company-initiated buybacks/sales. The document is very short, suggesting an announcement rather than a formal regulatory filing form, but the content is specific enough for DIRS.
2023-08-21 English
Carasent: Q2 2023 Financial Results and Presentation
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report Q2 2023' and contains substantive financial data, including revenue growth percentages, cost savings analysis, and financial summaries for the second quarter. It provides a detailed review of business performance and financial metrics, fitting the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report, as it contains the actual financial highlights and analysis. Q2 2023
2023-07-14 English
Carasent: Q2 2023 Financial Results and Presentation
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for Carasent, covering Q2 and H1 2023. It includes detailed financial statements (income, cash flow, financial position), notes to the accounts, management commentary on performance, and key figures. It is not an announcement of a report (RPA) because it contains the actual financial data and analysis. It is not a full 10-K as it covers an interim period (Q2/H1). Therefore, it is classified as an Interim/Quarterly Report. Q2 2023
2023-07-14 English
Carasent: Q2 2023 Financial Results and Presentation
Report Publication Announcement Classification · 98% confidence The document text is extremely short (196 characters) and explicitly states: 'Attached please find Carasent ASA Q2 and H1 2023 Financial Results and Presentation.' This structure—a brief announcement stating that the actual results/presentation documents are attached or available—fits the definition of a Report Publication Announcement (RPA). It is not the full Financial Results (which would be IR or ER) or the Presentation itself (IP), but the announcement of their publication. Applying the 'MENU VS MEAL' rule, this is the announcement, not the meal.
2023-07-14 English
Invitation to presentation of Q2 2023 results
Report Publication Announcement Classification · 94% confidence The document is an 'Invitation to presentation of Q2 2023 results'. It announces a webcast and teleconference for presenting the Q2 2023 Financial Results on July 14th. This is not the actual results release (ER) or the full interim report (IR), but rather an announcement inviting participation in the event where those results will be discussed. Since the document is short and serves primarily to announce an upcoming event related to financial results presentation, it fits best as a Call Transcript (CT) if it were the transcript, or an announcement related to an earnings call. Given the options, an invitation to an earnings presentation/call is most closely related to the 'Call Transcript' (CT) category, as it pertains directly to the event where the results are discussed, or potentially a general Regulatory Filing (RNS). However, since it is an invitation to the event itself, and not the transcript or the results, it is a preparatory/logistical announcement. The closest fit among the provided options for an announcement about an earnings call/presentation event is often grouped with the call itself (CT) or treated as a general announcement (RNS). Given the context of financial reporting events, and the fact that it is an invitation to the Q&A session, CT is plausible, but RPA (Report Publication Announcement) is for announcing the *report*. Since this announces the *presentation* of the results, and it's not a standard regulatory filing, RNS is the safest fallback if CT is reserved strictly for the transcript. However, since the document is an invitation to the event where the results are discussed, and it is very short, it is most likely an announcement related to the earnings call. Let's re-evaluate: It is an invitation to the event where Q2 results are presented. This is highly specific to the earnings process. If the actual transcript were present, it would be CT. Since it's the invitation, it's a logistical announcement. Given the strict definitions, and the lack of a specific 'Earnings Call Invitation' code, RNS (Regulatory Filings - fallback) is appropriate, or perhaps it's considered part of the broader ER process. Since it's an invitation to the event, and not the results themselves, RNS is the most neutral classification for this logistical announcement.
2023-07-11 English
Flagging
Major Shareholding Notification Classification · 99% confidence The document text is very short (297 characters) and reports a specific transaction: Aeternum Capital AS purchased 871,815 shares in Carasent ASA, resulting in a total holding of 15.7% of the share capital. This describes a change in significant share ownership, crossing a threshold that requires notification. This aligns directly with the definition for Major Shareholding Notification (MRQ). It is not an earnings release, a full report, or a management change announcement.
2023-05-19 Norwegian

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.